Answers are grounded in this paper and cite their sources.
Compares oocyte vitrification methods for embryo development in equine, suggesting optimized protocols improve outcomes.
Oocyte vitrification is a key complement for equine in vitro embryo production, but most studies have focused on immature oocytes, leaving in vitro-matured (IVM) oocytes poorly studied. We compared 3 vitrification methods for horse IVM oocytes. Slaughterhouse-derived oocytes were matured in vitro, denuded, and fertilized fresh (control) or vitrified using Cryolock devices: (1) Kitazato-Short, with short exposure (23°C; VS1, 1 min; VS2, 30 s) and warming at 37°C in Thawing solution (TS; 1 min); (2) Kitazato-Long, same kit with conventional exposure (23°C; VS1, 10 min; VS2, 30 s) and warming at 37°C in TS (1 min), followed by Dilution Solution (DS) and Washing Solution (WS) at 23°C (3 and 5 min, respectively); (3) Custom-Made (Angel-Velez et al., Animals 2021; 11:3077) with exposure at 37°C to VS1 (Base solution [TCM 199 + 0.4% BSA] + 10% ethylene glycol [EG] + 10% propylene glycol [PG], 25 s) and VS2 (20% EG, 20% PG + 0.5 M galactose; 30 s), and warming in 0.3 M galactose in base solution (5 min). After warming, oocytes were incubated in IVM medium for 2 h before ICSI. After growth in Global medium + 10% FBS until d 5, embryos were switched to DMEM/F-12 + 10% FBS + 50 µg/mL gentamicin (38.2°C, 5% O 2 , 8.5% CO 2 , 86.5% N 2 ). Binomial models were used, with Firth’s penalized logistic regression for separation and a generalized linear mixed model for cleavage, using Holm-adjusted pairwise comparisons ( P < 0.05). Survival (intact oolemma/vitrified) varied among treatments ( P < 0.001). Survival rates were considerably lower in the Long (63.2 ± 2.5%; n = 44) and Custom (63.9 ± 14.8%; n = 51) groups compared with control (100%; n = 40), whereas Kitazato-Short (85.3 ± 2.1%; n = 55) tended to show higher survival among vitrified oocytes ( P = 0.06) and no difference with control ( P = 0.13). Cleavage was lower in the Long group (29.9 ± 9.0%) compared with control (61.6 ± 3.2%; P = 0.026) but did not differ among vitrification methods (46.0 ± 9.4% [Short] and 51.0 ± 1.0% [Custom]; P > 0.6). Embryo development was affected by vitrification ( P < 0.001), with mean blastocyst rates over injected oocytes higher in control (38.9 ± 5.6%), versus Short (6.1 ± 3.6%), Long (0%), and Custom (2.0 ± 2%). In conclusion, limiting cryoprotectant exposure partially protects post-warming oocyte competency. However, vitrification of IVM horse oocytes still affects embryo development relative to fresh controls, making exposure times and cryoprotectant concentrations critical for protocol improvement.
No takes yet. Share an insight, caveat, or question.
Angel-Velez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: